AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Advanced Metastatic Castration Resistant Prostate Cancer

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer NCT06609005Phase 1, Phase 222 sites๐Ÿ“ Scottsdale๐Ÿ“ Newport Beach๐Ÿ“ Orange Shenzhen Ionova Life Sciences Co., Ltd. ยท Tests: INV-9956 Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors NCT07288359Phase 1, Phase 216 sites๐Ÿ“ Atlanta๐Ÿ“ Nashville๐Ÿ“ San Antonio Novartis Pharmaceuticals ยท Tests: GVV858, Fulvestrant, Letrozole Imaging of Solid Tumors Using 18F-TRX NCT06942104Phase 11 site๐Ÿ“ San Francisco Rahul Aggarwal ยท Tests: 18F-TRX, Positron Emission Tomography (PET)/Computerized tomography (CT), Tumor Biopsy, Blood Specimen Collection A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1) NCT07723248Phase 312 sites๐Ÿ“ Coral Springs๐Ÿ“ Jeffersonville๐Ÿ“ Holland ORIC Pharmaceuticals ยท Tests: Rinzimetostat, Darolutamide, Enzalutamide, Docetaxel Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer NCT07667400Phase 1, Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: SX-682, DTX A Study of NX-1607 in Adults With Advanced Malignancies NCT05107674Phase 117 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ San Francisco Nurix Therapeutics, Inc. ยท Tests: NX-1607, Paclitaxel Dual-target PSMA/PSCA CAR-NK Cells in Advanced Prostate Cancer NCT07641049Phase 11 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: ETB-DualNK-01, Fludarabine, Cyclophosphamide Study of DCC-2812 in Participants With Advanced Genitourinary Cancers NCT06966024Phase 18 sites๐Ÿ“ Boston๐Ÿ“ Ann Arbor๐Ÿ“ St Louis Deciphera Pharmaceuticals, LLC ยท Tests: DCC-2812 A Study of DB-1310 in Advanced/Metastatic Solid Tumors NCT05785741Phase 1, Phase 224 sites๐Ÿ“ Sacramento๐Ÿ“ Santa Monica๐Ÿ“ Coral Gables DualityBio Inc. ยท Tests: DB-1310, Trastuzumab, Osimertinib, capecitabine A Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors NCT07887971Phase 11 site๐Ÿ“ Miami Aktis Oncology, Inc. ยท Tests: [225Ac]Ac-AKY-2519 (therapeutic), [64Cu]Cu-AKY-2519 (imaging) A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer NCT07005154Phase 254 sites๐Ÿ“ Huntsville๐Ÿ“ San Diego๐Ÿ“ Tampa Astellas Pharma Global Development, Inc. ยท Tests: ASP5541, Prednisone, Prednisolone, abiraterone acetate, Adrenocorticotropic hormone A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer NCT05125016Phase 1, Phase 214 sites๐Ÿ“ Palo Alto๐Ÿ“ New Haven๐Ÿ“ Louisville Regeneron Pharmaceuticals ยท Tests: REGN4336, REGN5678 A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer NCT07189403Phase 16 sites๐Ÿ“ Sarasota๐Ÿ“ New York๐Ÿ“ Providence Daiichi Sankyo ยท Tests: DS9051b A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours NCT07533708Phase 15 sites๐Ÿ“ Nanchang๐Ÿ“ Naning๐Ÿ“ Nanjing Shanghai Henlius Biotech ยท Tests: HLX3902 AXT-1003 Combination With Enzalutamide in Participants With mCRPC NCT07897071Phase 14 sites๐Ÿ“ Guangzhou๐Ÿ“ Changsha๐Ÿ“ Shanghai Axter Therapeutics (Beijing) Co., Ltd ยท Tests: AXT-1003, Enzalutamide, AXT-1003, Enzalutamide 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors NCT07189871Phase 1, Phase 25 sites๐Ÿ“ Dothan๐Ÿ“ Grand Rapids๐Ÿ“ Omaha Radiopharm Theranostics, Ltd ยท Tests: 177Lu-BetaBart, BetaBart + unlabeled BetaBart A Study of MGC026 in Participants With Advanced Solid Tumors NCT06242470Phase 112 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Lake Success MacroGenics ยท Tests: MGC026 Dose Escalation, MGC026 Dose for Expansion, Pembrollizumab, vobramitamab tavatecan A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors NCT07277270Phase 122 sites๐Ÿ“ Reunion๐Ÿ“ New Hyde Park๐Ÿ“ Philadelphia GlaxoSmithKline ยท Tests: GSK5764227, Bevacizumab, Fluorouracil, leucovorin, Enzalutamide First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) NCT06217822Phase 135 sites๐Ÿ“ Duarte๐Ÿ“ Minneapolis๐Ÿ“ Omaha Bayer ยท Tests: 225Ac-PSMA-Trillium (BAY3563254) A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types NCT07503808Phase 115 sites๐Ÿ“ Denver๐Ÿ“ Sarasota๐Ÿ“ Detroit IDEAYA Biosciences ยท Tests: IDE034 A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas NCT04104776Phase 1, Phase 280 sites๐Ÿ“ Tampa๐Ÿ“ Atlanta๐Ÿ“ Chicago Novartis Pharmaceuticals ยท Tests: Tulmimetostat, Enzalutamide A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas NCT06999187Phase 110 sites๐Ÿ“ Denver๐Ÿ“ Orlando๐Ÿ“ Sarasota Dren Bio ยท Tests: DR-0202 Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) NCT05489211Phase 296 sites๐Ÿ“ Los Angeles๐Ÿ“ San Diego๐Ÿ“ Santa Rosa AstraZeneca ยท Tests: Datopotamab deruxtecan (Dato-DXd), Capecitabine, 5-Fluorouracil, Volrustomig, Carboplatin A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer NCT04729114Phase 125 sites๐Ÿ“ Tucson๐Ÿ“ Anaheim๐Ÿ“ Santa Rosa Astellas Pharma Global Development, Inc. ยท Tests: PRL-02 injection, prednisone, dexamethasone, enzalutamide A Study of MHB048C in Patients With Advanced Solid Tumors NCT07192120Phase 1, Phase 21 site๐Ÿ“ Shanghai Minghui Pharmaceutical (Hangzhou) Ltd ยท Tests: MHB048C for Injection A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer NCT07339267Phase 11 site๐Ÿ“ Beijing Astellas Pharma Global Development, Inc. ยท Tests: ASP5541, Prednisone TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy NCT07514065Phase 11 site๐Ÿ“ Shanghai Tasly Pharmaceutical Group Co., Ltd ยท Tests: Treatment arm: TSL2109 capsulesใ€‚Oral administrationใ€‚ A Study in Patients With Metastatic Castration-Resistant Prostate Cancer NCT07719361Phase 110 sites๐Ÿ“ Los Angeles๐Ÿ“ Boston๐Ÿ“ Boston Flare Therapeutics Inc. ยท Tests: FX-111 Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) NCT05942001Phase 11 site๐Ÿ“ Shanghai Jiangsu HengRui Medicine Co., Ltd. ยท Tests: HRS-5041, Docetaxel injection, Abiraterone acetate tablets, Prednisone Acetate Tablets, Enzalutamide Soft Capsules Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors NCT06784193Phase 125 sites๐Ÿ“ Gilbert๐Ÿ“ Aurora๐Ÿ“ Sarasota Olema Pharmaceuticals, Inc. ยท Tests: OP-3136, Fulvestrant, Palazestrant
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy